Tobón GJ, Youinou P, Saraux A. The setting, geo-epidemiology, and autoimmune illness: rheumatoid arthritis. Autoimmun Rev. 2010;9:A288–292.
Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto Okay. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–38.
Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019;170:Itc1–16.
Wynn TA, Chawla A, Pollard JW. Macrophage biology in improvement, homeostasis and illness. Nature. 2013;496:445–55.
Mosser DM, Edwards JP. Exploring the complete spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958–69.
Wang J, Wu Y, Li G, Zhou F, Wu X, Wang M, et al. Engineering large-scale self-mineralizing bone organoids with bone matrix-inspired hydroxyapatite hybrid bioinks. Adv Mater. 2024;36:e2309875.
Shin TH, Kim HS, Kang TW, Lee BC, Lee HY, Kim YJ, Shin JH, Website positioning Y, Gained Choi S, Lee S, et al. Human umbilical wire blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Loss of life Dis. 2016;7:e2524.
Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL. A quantitative, randomized research evaluating three strategies of mesenchymal stem cell supply following myocardial infarction. Eur Coronary heart J. 2006;27:1114–22.
Mathieu M, Martin-Jaular L, Lavieu G, Théry C. Specificities of secretion and uptake of exosomes and different extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21:9–17.
Liu H, Tune P, Zhang H, Zhou F, Ji N, Wang M, Zhou G, Han R, Liu X, Weng W, et al. Artificial biology-based bacterial extracellular vesicles displaying BMP-2 and CXCR4 to ameliorate osteoporosis. J Extracell Vesicles. 2024;13:e12429.
Li H, Feng Y, Zheng X, Jia M, Mei Z, Wang Y, Zhang Z, Zhou M, Li C. M2-type exosomes nanoparticles for rheumatoid arthritis remedy by way of macrophage re-polarization. J Management Launch. 2022;341:16–30.
Wang Z, Zhang C, Meng J, Jiao Z, Bao W, Tian H, Wu C, Chai W, Li R, Liu Z, et al. A focused Exosome Therapeutic confers each CfDNA scavenging and macrophage polarization for ameliorating rheumatoid arthritis. Adv Mater. 2023;35:e2302503.
Wang F, Tune P, Wang J, Wang S, Liu Y, Bai L, et al. Organoid bioinks: development and utility. Biofabrication. 2024;16:032006.
Imai T, Takahashi Y, Nishikawa M, Kato Okay, Morishita M, Yamashita T, Matsumoto A, Charoenviriyakul C, Takakura Y. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. J Extracell Vesicles. 2015;4:26238.
Lai CP, Mardini O, Ericsson M, Prabhakar S, Maguire C, Chen JW, Tannous BA, Breakefield XO. Dynamic biodistribution of extracellular vesicles in vivo utilizing a multimodal imaging reporter. ACS Nano. 2014;8:483–94.
Hu Y, Li X, Zhang Q, Gu Z, Luo Y, Guo J, Wang X, Jing Y, Chen X, Su J. Exosome-guided bone focused supply of Antagomir-188 as an anabolic remedy for bone loss. Bioact Mater. 2021;6:2905–13.
Han R, Wu Y, Han Y, Liu X, Liu H, Su J. Engineered plant extracellular vesicles for autoimmune ailments remedy. Nano Res. 2023;17:2857–73.
Cong M, Tan S, Li S, Gao L, Huang L, Zhang HG, Qiao H. Know-how perception: plant-derived vesicles-how removed from the scientific biotherapeutics and therapeutic drug carriers? Adv Drug Deliv Rev. 2022;182:114108.
Kim J, Li S, Zhang S, Wang J. Plant-derived exosome-like nanoparticles and their therapeutic actions. Asian J Pharm Sci. 2022;17:53–69.
Hwang J-H, Park Y-S, Kim H-S, Kim D-h, Lee S-H, Lee C-H, Lee S-H, Kim J-E, Lee S, Kim HM, et al. Yam-derived exosome-like nanovesicles stimulate osteoblast formation and forestall osteoporosis in mice. J J Management Launch. 2023;355:184–98.
Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, Han MK, Xiao B, Xu C, Srinivasan S, Merlin D. Edible ginger-derived nanoparticles: a novel therapeutic method for the prevention and therapy of inflammatory bowel illness and colitis-associated most cancers. Biomaterials. 2016;101:321–40.
Ju S, Mu J, Dokland T, Zhuang X, Wang Q, Jiang H, Xiang X, Deng ZB, Wang B, Zhang L, et al. Grape exosome-like nanoparticles induce intestinal stem cells and defend mice from DSS-induced colitis. Mol Ther. 2013;21:1345–57.
Deng Z, Rong Y, Teng Y, Mu J, Zhuang X, Tseng M, Samykutty A, Zhang L, Yan J, Miller D, et al. Broccoli-derived nanoparticle inhibits mouse colitis by activating dendritic cell AMP-Activated protein kinase. Mol Ther. 2017;25:1641–54.
Xu XH, Yuan TJ, Dad HA, Shi MY, Huang YY, Jiang ZH, Peng LH. Plant exosomes as novel nanoplatforms for MicroRNA switch stimulate neural differentiation of stem cells in Vitro and in vivo. Nano Lett. 2021;21:8151–9.
Jo S, Samarpita S, Lee JS, Lee YJ, Son JE, Jeong M, Kim JH, Hong S, Yoo SA, Kim WU, et al. 8-Shogaol inhibits rheumatoid arthritis by way of focusing on TAK1. Pharmacol Res. 2022;178:106176.
Zhang YM, Shen J, Zhao JM, Guan J, Wei XR, Miao DY, Li W, Xie YC, Zhao YQ. Cedrol from Ginger ameliorates rheumatoid arthritis by way of lowering irritation and selectively inhibiting JAK3 phosphorylation. J Agric Meals Chem. 2021;69:5332–43.
Chando A, Basudkar V, Gharat S, Momin M, Khan T. Growth and preclinical evaluation of nanoemulgel loaded with phytoconstituents for the administration of rheumatoid arthritis. Drug Deliv Transl Res. 2024;14:524–41.
Villalvilla A, da Silva JA, Largo R, Gualillo O, Vieira PC, Herrero-Beaumont G, Gómez R. 6-Shogaol inhibits chondrocytes’ innate immune responses and cathepsin-Okay exercise. Mol Nutr Meals Res. 2014;58:256–66.
Li N, Li X, Deng L, Yang H, Gong Z, Wang Q, Pan D, Zeng S, Chen J. 6-Shogaol inhibits the proliferation, apoptosis, and migration of rheumatoid arthritis fibroblast-like synoviocytes by way of the PI3K/AKT/NF-κB pathway. Phytomedicine. 2023;109:154562.
Chen X, Zhou Y, Yu J. Exosome-like nanoparticles from Ginger rhizomes Inhibited NLRP3 inflammasome activation. Mol Pharm. 2019;16:2690–9.
Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng JX, Low PS. A purposeful folate receptor is induced throughout macrophage activation and can be utilized to focus on medication to activated macrophages. Blood. 2009;113:438–46.
Yang M, Liu X, Luo Q, Xu L, Chen F. An environment friendly methodology to isolate lemon derived extracellular vesicles for gastric most cancers remedy. J Nanobiotechnol. 2020;18:100.
Tune H, Li X, Zhao Z, Qian J, Wang Y, Cui J, Weng W, Cao L, Chen X, Hu Y, Su J. Reversal of osteoporotic exercise by endothelial cell-secreted bone focusing on and biocompatible exosomes. Nano Lett. 2019;19:3040–8.
Gardiner C, Di Vizio D, Sahoo S, Théry C, Witwer KW, Wauben M, Hill AF. Strategies used for the isolation and characterization of extracellular vesicles: outcomes of a worldwide survey. J Extracell Vesicles. 2016;5:32945.
Liu H, Zhang Q, Wang S, Weng W, Jing Y, Su J. Bacterial extracellular vesicles as bioactive nanocarriers for drug supply: advances and views. Bioact Mater. 2022;14:169–81.
Chandrupatla D, Molthoff CFM, Lammertsma AA, van der Laken CJ, Jansen G. The folate receptor β as a macrophage-mediated imaging and therapeutic goal in rheumatoid arthritis. Drug Deliv Transl Res. 2019;9:366–78.
Yan F, Zhong Z, Wang Y, Feng Y, Mei Z, Li H, Chen X, Cai L, Li C. Exosome-based biomimetic nanoparticles focused to infected joints for enhanced therapy of rheumatoid arthritis. J Nanobiotechnol. 2020;18:115.
Kooijmans SAA, Fliervoet LAL, van der Meel R, Fens M, Heijnen HFG, van Bergen En Henegouwen PMP, Vader P, Schiffelers RM. PEGylated and focused extracellular vesicles show enhanced cell specificity and circulation time. J Management Launch. 2016;224:77–85.
Yin L, Yan L, Yu Q, Wang J, Liu C, Wang L, Zheng L. Characterization of the MicroRNA Profile of Ginger Exosome-like nanoparticles and their anti-inflammatory results in Intestinal Caco-2 cells. J Agric Meals Chem. 2022;70:4725–34.
Zhuang X, Deng ZB, Mu J, Zhang L, Yan J, Miller D, Feng W, McClain CJ, Zhang HG. Ginger-derived nanoparticles defend towards alcohol-induced liver harm. J Extracell Vesicles. 2015;4:28713.
Deng Y, Zhou Y, Liang Q, Ge C, Yang J, Shan B, Liu Y, Zhou X, Yin L. Irritation-instructed hierarchical supply of IL-4/miR-21 orchestrates Osteoimmune Microenvironment towards the therapy of rheumatoid arthritis. Adv Funct Mater. 2021;31:2101033.
Kim J, Kim HY, Tune SY, Go SH, Sohn HS, Baik S, Soh M, Kim Okay, Kim D, Kim HC, et al. Synergistic oxygen technology and reactive oxygen species scavenging by Manganese Ferrite/Ceria co-decorated nanoparticles for rheumatoid arthritis therapy. ACS Nano. 2019;13:3206–17.
Jain S, Tran TH, Amiji M. Macrophage repolarization with focused alginate nanoparticles containing IL-10 plasmid DNA for the therapy of experimental arthritis. Biomaterials. 2015;61:162–77.
Valadi H, Ekström Okay, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated switch of mRNAs and microRNAs is a novel mechanism of genetic change between cells. Nat Cell Biol. 2007;9:654–9.
Liu H, Wu Y, Wang F, Wang S, Ji N, Wang M, Zhou G, Han R, Liu X, Weng W, et al. Bone-targeted engineered bacterial extracellular vesicles delivering miRNA to deal with osteoporosis. Compos Half B-Eng. 2023;267:111047.
Chin AR, Fong MY, Somlo G, Wu J, Swiderski P, Wu X, Wang SE. Cross-kingdom inhibition of breast most cancers progress by plant miR159. Cell Res. 2016;26:217–28.
Zhou Z, Li X, Liu J, Dong L, Chen Q, Liu J, Kong H, Zhang Q, Qi X, Hou D, et al. Honeysuckle-encoded atypical microRNA2911 instantly targets influenza a viruses. Cell Res. 2015;25:39–49.
Li D, Yao X, Yue J, Fang Y, Cao G, Midgley AC, Nishinari Okay, Yang Y. Advances in Bioactivity of MicroRNAs of Plant-Derived Exosome-Like nanoparticles and milk-derived extracellular vesicles. J Agric Meals Chem. 2022;70:6285–99.
Huang R, Jia B, Su D, Li M, Xu Z, He C, Huang Y, Fan H, Chen H, Cheng F. Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic remedy of autoimmune pores and skin issues. J Extracell Vesicles. 2023;12:e12361.
Ren Y, Solar-Waterhouse D, Ouyang F, Tan X, Li D, Xu L, Li B, Wang Y, Li F. Apple phenolic extracts ameliorate lead-induced cognitive impairment and depression- and anxiety-like conduct in mice by abating oxidative stress, irritation and apoptosis by way of the miR-22-3p/SIRT1 axis. Meals Funct. 2022;13:2647–61.
Wu J, Kuang L, Chen C, Yang J, Zeng WN, Li T, Chen H, Huang S, Fu Z, Li J, et al. Mir-100-5p-abundant exosomes derived from infrapatellar fats pad MSCs defend articular cartilage and ameliorate gait abnormalities by way of inhibition of mTOR in osteoarthritis. Biomaterials. 2019;206:87–100.
Lu Y, Liu M, Guo X, Wang P, Zeng F, Wang H, Tang J, Qin Z, Tao T. miR-26a-5p alleviates CFA-induced continual inflammatory hyperalgesia by way of Wnt5a/CaMKII/NFAT signaling in mice. CNS Neurosci Ther. 2023;29:1254–71.
Shi L, Xu P, Hou L, Liu C, Jia H, Pang Y, Xiao Y. ADSCs-exosomal mir-21-5p modulates neuroinflammatory response by focusing on STAT3 in cerebral infarction. J Drug Supply Sci Technol. 2023;89:105061.
Youn YJ, Shrestha S, Lee YB, Kim JK, Lee JH, Hur Okay, Mali NM, Nam SW, Kim SH, Lee S, et al. Neutrophil-derived path is a proinflammatory subtype of neutrophil-derived extracellular vesicles. Theranostics. 2021;11:2770–87.
Zhao HY, Zhang YY, Xing T, Tang SQ, Wen Q, Lyu ZS, Lv M, Wang Y, Xu LP, Zhang XH, et al. M2 macrophages, however not M1 macrophages, assist megakaryopoiesis by upregulating PI3K-AKT pathway exercise. Sign Transduct Goal Ther. 2021;6:234.
Wang Y, Lin Q, Zhang H, Wang S, Cui J, Hu Y, Liu J, Li M, Zhang Okay, Zhou F, et al. M2 macrophage-derived exosomes promote diabetic fracture therapeutic by performing as an immunomodulator. Bioact Mater. 2023;28:273–83.
Liu S, Ma H, Zhang H, Deng C, Xin P. Latest advances on signaling pathways and their inhibitors in rheumatoid arthritis. Clin Immunol. 2021;230:108793.
Schett G, Elewaut D, McInnes IB, Dayer JM, Neurath MF. How cytokine networks gas irritation: towards a cytokine-based illness taxonomy. Nat Med. 2013;19:822–4.
Yokota Okay, Sato Okay, Miyazaki T, Aizaki Y, Tanaka S, Sekikawa M, Kozu N, Kadono Y, Oda H, Mimura T. Characterization and performance of Tumor Necrosis issue and interleukin-6-Induced osteoclasts in rheumatoid arthritis. Arthritis Rheumatol. 2021;73:1145–54.
Saul JM, Annapragada A, Natarajan JV, Bellamkonda RV. Managed focusing on of liposomal doxorubicin by way of the folate receptor in vitro. J Management Launch. 2003;92:49–67.
Model DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2:1269–75.
